SCHEMBL29339883

SCHEMBL29339883

CCc1nn(Cc2ccc(OC)cc2)cc1Cc1ccccc1Br

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AADAT Q8N5Z0 1/20 0.40
TSHR P16473 2/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
CYP19A1 P11511 1/20 0.39
PTGS2 P35354 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
NPC1 O15118 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
RAB9A P51151 3/20 0.38
CACNA1G O43497 1/20 0.37
CACNA1H O95180 1/20 0.37
CACNA1I Q9P0X4 1/20 0.37
LTA4H P09960 1/20 0.37
GAA P10253 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29339783 0.85 LTA4H (0.51) AADATALDH1A1LMNACYP19A1SIGMAR1
SCHEMBL29339884 0.77 KMT2A (0.37) AADATTSHRALDH1A1LMNAHPGD
SCHEMBL4552450 0.75 MEN1 (0.45) AADATALDH1A1CYP19A1PTGS2SIGMAR1
SCHEMBL30837375 0.74 LTA4H (0.60) TSHRALDH1A1LMNAHPGDHTT
SCHEMBL3902050 0.74 LTA4H (0.60) TSHRALDH1A1LMNAHPGDHTT
SCHEMBL29339971 0.74 DRD1 (0.53) LTA4HSMN1; SMN2
SCHEMBL29339707 0.74 MEN1 (0.44) AADATALDH1A1CYP19A1PTGS2SIGMAR1
SCHEMBL31052484 0.74 AADAT (0.49) AADATALDH1A1CYP19A1PTGS2NPC1
SCHEMBL24483861 0.73 LTA4H (0.51) AADATALDH1A1HTTCYP19A1SIGMAR1
SCHEMBL16784448 0.72 KMT2A (0.57) AADATALDH1A1CYP19A1PTGS2SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF CORNELL UNIVERSITY (US) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239774-A1 SOLUBLE ADENYLYL CYCLASE (SAC) INHIBITORS AND USES THEREOF UACA, ADCYAP1R1, ADCY1 AADAT 1363/4885TSHR 1060/4885ALDH1A1 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.